⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

AI Visibility Scorecard

Advancing the Treatment of Ophthalmic Diseases | Glaukos

Advancing the Treatment of Ophthalmic Diseases | Glaukos

Unclaimed

ilinkprovider.com · Healthcare

Borderline visible. AI bots can crawl Advancing the Treatment of Ophthalmic Diseases | Glaukos, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

Monitoring for AI engine activity

In the Engagemii AEO index

#538,236 of 839,159 in Healthcare for AI visibility

4.3

/10

AEO Score

Share

About Advancing the Treatment of Ophthalmic Diseases | Glaukos

from our crawl and measurement

Advancing the Treatment of Ophthalmic Diseases describes itself simply: "Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 4.1 out of 10.

Our crawl found structured data on the page (WebPage, BreadcrumbList, WebSite) and a readable heading structure. It is missing an llms.txt file and a sitemap.

Industry · Healthcare
Last scored · Aug 12, 2026

The 6 signals AI reads

Higher is better · 0-10

Structured Data

3

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

8

Clear headings and answer-style content.

Entity Clarity

5

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

5

Experience, Expertise, Authority, Trust markers.

Technical AEO

6

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

8

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

1

Inbound links from other sites.

Domain Authority

0

Little domain authority yet.

Reference Presence

0

Not in AI knowledge graphs yet.

News & Press

0

No press coverage found yet.

Community

0

No community discussion yet.

Social Mentions

0

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.3/10, Advancing the Treatment of Ophthalmic Diseases | Glaukos is crawlable but under-signaled - fixable, and the signals above are where to start.

Is this your brand?

The exact fixes for Advancing the Treatment of Ophthalmic Diseases | Glaukos

Which AI engines already crawl you

Weekly ChatGPT & Claude citation tracking

Already have an account? Sign in

Picked for Advancing the Treatment of Ophthalmic Diseases | Glaukos: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Advancing the Treatment of Ophthalmic Diseases | Glaukos.

Source & Attribution

Scored by Engagemii on August 12, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/ilinkprovider

Cite this score: Engagemii (2026). "AEO Score for Advancing the Treatment of Ophthalmic Diseases | Glaukos." Retrieved from https://engagemii.com/aeo/brands/ilinkprovider

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform